title: Giant prolactinomas: Multi-modal approach to achieve tumor control.
authors.affiliation: Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ilanshi@clalit.org.il.
authors.forename: Ilan
authors.identifier: http://orcid.org/0000-0002-9188-3894
authors.initials: I
authors.lastname: Shimon
mesh_terms: D003131:Combined Modality Therapy / Q000009:adverse effects / Q000639:trends; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D017410:Practice Guidelines as Topic; D015175:Prolactinoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D018491:Dopamine Agonists